News | January 28, 2025
Torrent Pharmaceuticals posts Q3 FY25 consolidated PAT at Rs. 503 Cr
Torrent Pharmaceuticals has reported total income of Rs. 2,842 crores during the period ended December 31, 2024
Torrent Pharmaceuticals has reported total income of Rs. 2,842 crores during the period ended December 31, 2024
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies
Groundbreaking collaboration harnesses AI-driven insights and advanced manufacturing to create next-generation adjuvants for emerging biological threats
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
The company is committed to unlocking new frontiers in neuroscience and developing Usnoflast for patients with ALS
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
New Jersey-based manufacturing site to support innovative decentralized approach for improved patient experience
Datroway is the eighth new medicine of the 20 AstraZeneca has set out to deliver by 2030
With over 28 years of experience in the pharmaceutical industry, he is a seasoned Techno? Commercial professional and accomplished top management leader
atulya keratin & wheat protein shampoo has force of natural ingredients like extract of wheat, fenugreek, reetha & almond oil
Subscribe To Our Newsletter & Stay Updated
